Enantiomerically Pure Indole Compounds for AhR Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer and immune stimulation lack effective modulation of the aryl hydrocarbon receptor (AhR) activity, which is crucial for various biological processes including cell differentiation, apoptosis, and immune system modulation.
Innovation Solution
Development of specific indole compounds with defined structures, such as those described in formulas 2, 2a, 3, 3a, 3b, 3c, 4, 5, and 6, which are enantiomerically pure and can form three- to twelve-membered rings, to modulate AhR activity, thereby treating diseases and conditions benefiting from AhR modulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cancer treatments are used, then cancer therapy is provided, but effective modulation of AhR activity is not achieved
Solution Approach 1:
The patent modifies the chemical structure of indole compounds by changing parameters such as substituent types at specific positions (R1-R9), heteroatom configurations (X1-X4), and stereochemical configurations (enantiomerically pure compounds). These parameter changes enable the compounds to effectively modulate AhR activity, resolving the contradiction between conventional treatment limitations and the need for reliable AhR modulation.
Solution Approach 2:
The patent creates composite molecular structures by combining indole core compounds with various functional groups and substituents (formulae 2, 2a, 3, 3a, 3b, 3c, 4, 5, and 6). These composite structures achieve both cancer treatment efficacy and reliable AhR activity modulation, addressing the technical contradiction through molecular design integration.
2Reliability
If immune stimulation is provided, then immune system activity is enhanced, but specific AhR modulation is not achieved
Solution Approach 1:
The patent applies local quality by introducing specific functional groups and substituents at defined positions in the indole compound structure. This localized molecular modification enables selective AhR modulation while maintaining immune stimulation effects, achieving both reliability of AhR modulation and specificity of immune response.
Solution Approach 2:
The indole compounds serve as intermediary substances that mediate between immune stimulation and AhR modulation. These compounds can be administered to achieve both immune system enhancement and specific AhR activity control, resolving the contradiction through their dual-functional molecular design.
Data Source
AI summary
The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.